Receptor Subtype for Vasopressin-Induced Release of Nitric Oxide From Rat Kidney

Hypertension

Volumn 29, Issue 1, 1997, Pages 58-64

  Hirata, Yasunobu ^a   Hayawaka, Hiroshi ^a   Kakoki, Masao ^a   Tojo, Akihiro ^a   Suzuki, Etsu ^a   Nagata, Daisuke ^a   Kimura, Kenjiro ^a   Goto, Atsuo ^a   Kikuchi, Kazuya ^a   Nagano, Tetsuo ^a   Hirobe, Masaaki ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; DEOXYCORTICOSTERONE ACETATE; DESMOPRESSIN; MOZAVAPTAN; N(G) METHYLARGININE; NITRIC OXIDE; PHENYLEPHRINE; RECEPTOR SUBTYPE; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; ISOLATED KIDNEY; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; ARGININE VASOPRESSIN; BENZAZEPINES; DESOXYCORTICOSTERONE; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; KIDNEY; MALE; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PERFUSION; PIPERIDINES; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; RENAL AGENTS;

EID: 0031041231     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.29.1.58     Document Type: Article

References (33)

1. Nabika T, Velletri PA, Lowenberg W, Beaven MA. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [arg]vasopressin in vascular smooth muscle cells. J Biol Chem. 1985;260:4661-4670.
2. Thibonnier M. Vasopressin and blood pressure. Kidney Int. 1988;34(suppl 25):S52-S56.
3. Katusic ZS, Shepherd JT, Vanhoutte PM. Vasopressin causes endothelium dependent relaxations of the canine basilar artery. Circ Res. 1984;55:575-579.
4. Katusic ZS. Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin. Am J Physiol. 1992;262:H1557-H1562.
5. Walker BR, Haynes J Jr, Wang HL, Voelkel NF. Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol. 1989;257:H415-H422.
6. 2 receptor. J Clin Invest. 1989;84:418-426.
7. 1 receptor antagonist in humans. Hypertension. 1992;20:54-58.
8. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Hirooka Y, Ando S, Takeshita A. Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest. 1993;92:1483-1490.
9. 2 receptors in conscious dogs. Am J Physiol. 1993;265:R934-R942.
10. 2 -induced vasodilation in dogs. Am J Physiol. 1994;266:H99-H106.
11. 2 vasopressin-receptor-mediated renal vasodilation. J Cardiovasc Pharmacol. 1994;23:331-336.
12. Yamada K, Nakayama M, Nakano H, Mimura N, Yoshida S. Endothelium-dependent vasorelaxation evoked by desmopressin and involvement of nitric oxide in rat aorta. Am J Physiol. 1993;264:E203-E207.
13. Hassid A, Williams C. Vasoconstrictor-evoked prostaglandin synthesis in cultured vascular smooth muscle. Am J Physiol. 1987;245:C278-C282.
14. Floras JS, Aylward PE, Abboud FM, Mark AL. Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin. Hypertension. 1987;10:409-416.
15. Schini VB, Katusic ZS, Vanhoutte PM. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther. 1990;255:994-1000.
16. 2 system. Anal Chem. 1993;65:1794-1799.
17. 2 chemiluminescence method. J Biol Chem. 1993;268:23106-23110.
18. Hayakawa H, Hirata Y, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M. Long-term administration of L-arginine improves nitric oxide release from kidney in DOCA-salt hypertensive rats. Hypertension. 1994;23:752-756.
19. Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation. 1995;91:1229-1235.
20. Huttner I, Gabbiani G. Vascular endothelium in hypertension. In: Genest J, Kuchel O, Hamet P, Cantin M, eds. Hypertension. Physiopathology and Treatment. 2nd ed. New York, NY: McGraw-Hill Publishing Co; 1983:473-488.
21. Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H, Sugimoto T. Role of endogenous ANP in DOCA-salt hypertensive rats: effects of a novel non-peptide antagonist for ANP receptor. Circulation. 1993;87:554-561.
22. 1 receptor antagonist. Science. 1991;252:572-574.
23. 2 receptor antagonist. Br J Pharmacol. 1992;105:787-791.
24. Tojo A, Gross SS, Zhang L, Tisher CC, Schmidt HHHW, Wilcox CS, Madsen KM. Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J Am Soc Nephrol. 1994;4:1438-1447.
25. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HHHW. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A. 1992;89:11993-11997.
26. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992;89:6348-6352.
27. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 1992;90:2092-2096.
28. Imai T, Hirata Y, Kanno K, Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest. 1994;93:543-549.
29. 2 selective ligands. Endocrinology. 1990;126:1478-1484.
30. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest. 1993;92:2339-2345.
31. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991;18:165-170.
32. Matsui H, Kohmoto O, Hirata Y, Serizawa T. Effects of a non-peptide vasopressin antagonist (OPC-21268) in smooth muscle cells and ventricular myocytes. Hypertension. 1992;19:730-733.
33. Berecek KH, Zhang L. Biochemistry and cell biology of angiotensin-converting enzyme and converting enzyme inhibitors. In: Mukhopadhyay AK, Raizada MK, eds. Tissue Renin-Angiotensin Systems. New York, NY: Plenum Press; 1995:141-168.